{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T06:17:23Z","timestamp":1768889843400,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T00:00:00Z","timestamp":1426550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","doi-asserted-by":"crossref","award":["R01 DK090181"],"award-info":[{"award-number":["R01 DK090181"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"crossref","award":["K23 DK095914"],"award-info":[{"award-number":["K23 DK095914"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"crossref","award":["K25 DK097279"],"award-info":[{"award-number":["K25 DK097279"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"crossref","award":["T32 DK007357"],"award-info":[{"award-number":["T32 DK007357"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1053\/j.ajkd.2015.02.339","type":"journal-article","created":{"date-parts":[[2015,5,3]],"date-time":"2015-05-03T02:27:54Z","timestamp":1430620074000},"page":"106-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Longer-term Outcomes of Darbepoetin Alfa Versus Epoetin Alfa\u00a0in Patients With ESRD Initiating Hemodialysis: A Quasi-experimental Cohort Study"],"prefix":"10.1053","volume":"66","author":[{"given":"Wolfgang C.","family":"Winkelmayer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara I.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya A.","family":"Mitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilee R.","family":"Wilhelm-Leen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn M.","family":"Chertow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Alan","family":"Brookhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin A.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2015.02.339_bib1","unstructured":"The Dialysis Outcomes and Practice Patterns Study. DOPPS Practice Monitor. Ann Arbor, MI: Arbor Research Collaborative for Health. http:\/\/www.dopps.org\/DPM\/Files\/ESA_use_c_overallTAB.htm. Accessed October 26,\u00a02013."},{"key":"10.1053\/j.ajkd.2015.02.339_bib2","series-title":"USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","first-page":"124","year":"2007"},{"key":"10.1053\/j.ajkd.2015.02.339_bib3","unstructured":"2012 Annual Report of the Dialysis Outcomes and Practice Patterns Study: Hemodialysis Data 1997-2011. Ann Arbor, MI: Arbor Research Collaborative for Health. http:\/\/www.dopps.org\/annualreport\/html\/esagroup_c_TAB2011.htm. Accessed October 26,\u00a02013."},{"key":"10.1053\/j.ajkd.2015.02.339_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/ajkd.2002.33919","article-title":"Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients","volume":"40","author":"Nissenson","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2015.02.339_bib5","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1046\/j.1523-1755.2002.00657.x","article-title":"Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients","volume":"62","author":"Vanrenterghem","year":"2002","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2015.02.339_bib6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1203165","article-title":"Peginesatide in patients with anemia undergoing hemodialysis","volume":"368","author":"Fishbane","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2015.02.339_bib7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1203166","article-title":"Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis","volume":"368","author":"Macdougall","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2015.02.339_bib8","doi-asserted-by":"crossref","unstructured":"Wilhelm-Leen ER, Winkelmayer WC. Mortality risk of darbepoetin alfa versus epoetin alfa in patients with CKD: systematic review and meta-analysis [published online ahead of print January 27, 2015]. Am J Kidney Dis. http:\/\/dx.doi.org\/10.1053\/j.ajkd.2014.12.012.","DOI":"10.1053\/j.ajkd.2014.12.012"},{"key":"10.1053\/j.ajkd.2015.02.339_bib9","first-page":"CD010590","article-title":"Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis","volume":"12","author":"Palmer","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.ajkd.2015.02.339_bib10","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/ajt.12197","article-title":"Outcomes after kidney transplantation of patients previously diagnosed with atrial fibrillation","volume":"13","author":"Lenihan","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2015.02.339_bib11","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"10.1053\/j.ajkd.2015.02.339_bib12","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.2215\/CJN.10141013","article-title":"Addressing missing data in clinical studies of kidney diseases","volume":"9","author":"Montez-Rath","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2015.02.339_bib13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1523-1755.2001.060002741.x","article-title":"Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency","volume":"60","author":"Locatelli","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2015.02.339_bib14","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1161\/CIRCULATIONAHA.111.071985","article-title":"What caused excess strokes in patients randomized to darbepoetin in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)?: no smoking gun","volume":"124","author":"Winkelmayer","year":"2011","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2015.02.339_bib15","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.V10112392","article-title":"Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients","volume":"10","author":"Macdougall","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"suppl 3","key":"10.1053\/j.ajkd.2015.02.339_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ndt\/16.suppl_3.3","article-title":"Development and characterization of novel erythropoiesis stimulating protein (NESP)","volume":"16","author":"Egrie","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2015.02.339_bib17","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1093\/clinchem\/48.11.2057","article-title":"Comparison of the isoelectric focusing patterns of darbepoetin alfa, recombinant human erythropoietin, and endogenous erythropoietin from human urine","volume":"48","author":"Catlin","year":"2002","journal-title":"Clin Chem"},{"key":"10.1053\/j.ajkd.2015.02.339_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1681\/ASN.2009111127","article-title":"Does TREAT give the boot to ESAs in the treatment of CKD anemia?","volume":"21","author":"Singh","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2015.02.339_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/jama.293.1.90","article-title":"New avenues of exploration for erythropoietin","volume":"293","author":"Maiese","year":"2005","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2015.02.339_bib20","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1053\/j.seminhematol.2007.04.008","article-title":"Erythropoietin and treatment of non-anemic conditions\u2014cardiovascular protection","volume":"44","author":"Fliser","year":"2007","journal-title":"Semin Hematol"},{"key":"10.1053\/j.ajkd.2015.02.339_bib21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1634\/stemcells.20-6-485","article-title":"EPO's alter ego: erythropoietin has multiple actions","volume":"20","author":"Lappin","year":"2002","journal-title":"Stem Cells"},{"issue":"suppl 3","key":"10.1053\/j.ajkd.2015.02.339_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1634\/theoncologist.8-suppl_3-18","article-title":"New insights into erythropoietin and epoetin alfa: mechanisms of action, target tissues, and clinical applications","volume":"8","author":"Weiss","year":"2003","journal-title":"Oncologist"},{"key":"10.1053\/j.ajkd.2015.02.339_bib23","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1046\/j.1523-1755.2003.00279.x","article-title":"Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin","volume":"64","author":"Bahlmann","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2015.02.339_bib24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1182\/blood-2003-04-1284","article-title":"Erythropoietin regulates endothelial progenitor cells","volume":"103","author":"Bahlmann","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.ajkd.2015.02.339_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.RES.85.3.221","article-title":"Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization","volume":"85","author":"Asahara","year":"1999","journal-title":"Circ Res"},{"key":"10.1053\/j.ajkd.2015.02.339_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/01.HYP.0000168923.92885.f7","article-title":"Therapeutic potential of endothelial progenitor cells in cardiovascular diseases","volume":"46","author":"Dzau","year":"2005","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2015.02.339_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.1098313","article-title":"Derivatives of erythropoietin that are tissue protective but not erythropoietic","volume":"305","author":"Leist","year":"2004","journal-title":"Science"},{"key":"10.1053\/j.ajkd.2015.02.339_bib28","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.0409329102","article-title":"A\u00a0nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury","volume":"102","author":"Fiordaliso","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.ajkd.2015.02.339_bib29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1682\/JRRD.2009.08.0108","article-title":"Validation of erythropoietin use data on Medicare's End-Stage Renal Disease Medical Evidence Report","volume":"47","author":"Fischer","year":"2010","journal-title":"J\u00a0Rehabil Res Dev"},{"key":"10.1053\/j.ajkd.2015.02.339_bib30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3109\/0886022X.2012.747967","article-title":"Form CMS-2728 data versus erythropoietin claims data: implications for quality of care studies","volume":"35","author":"Beaubrun","year":"2013","journal-title":"Ren Fail"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638615005326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638615005326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:31:52Z","timestamp":1759458712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638615005326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0272638615005326"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2015.02.339","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longer-term Outcomes of Darbepoetin Alfa Versus Epoetin Alfa\u00a0in Patients With ESRD Initiating Hemodialysis: A Quasi-experimental Cohort Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2015.02.339","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}